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Abstract
Objectives: We investigated whether using demographic characteristics and alarm symptoms can accurately predict cancer
in patients with dyspepsia in Iran, where upper GI cancers and H. pylori infection are common.
Methods: All consecutive patients referred to a tertiary gastroenterology clinic in Tehran, Iran, from 2002 to 2009 were
invited to participate in this study. Each patient completed a standard questionnaire and underwent upper gastrointestinal
endoscopy. Alarm symptoms included in the questionnaire were weight loss, dysphagia, GI bleeding, and persistent
vomiting. We used logistic regression models to estimate the diagnostic value of each variable in combination with other
ones, and to develop a risk-prediction model.
Results: A total of 2,847 patients with dyspepsia participated in this study, of whom 87 (3.1%) had upper GI malignancy.
Patients reporting at least one of the alarm symptoms constituted 66.7% of cancer patients compared to 38.9% in patients
without cancer (p,0.001). Esophageal or gastric cancers in patients with dyspepsia was associated with older age, being
male, and symptoms of weight loss and vomiting. Each single predictor had low sensitivity and specificity. Using a
combination of age, alarm symptoms, and smoking, we built a risk-prediction model that distinguished between high-risk
and low-risk individuals with an area under the ROC curve of 0.85 and acceptable calibration.
Conclusions: None of the predictors demonstrated high diagnostic accuracy. While our risk-prediction model had
reasonable accuracy, some cancer cases would have remained undiagnosed. Therefore, where available, low cost
endoscopy may be preferable for dyspeptic older patient or those with history of weight loss.
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Introduction
Dyspepsia, a condition defined as recurrent or persistent pain or
discomfort centered in the upper abdomen, [1] affects 25%–40%
of adults in the general population of the United States, incurring
over $12 billion per year in direct annual costs in the United States
and nearly £1 billion per year in the United Kingdom. [2–6]
Several benign or malignant disorders may underlie dyspepsia,
including esophagitis, gastroesophageal reflux disease (GERD),
peptic ulcer disease (PUD), erosive duodenitis, [7] and most
importantly upper gastrointestinal (UGI) malignancies, which are
estimated to be responsible for 1%–3% of all cases of dyspepsia.
[7–10] However, in over half of the dyspeptic patients no obvious
structural abnormality can be found, a condition called ‘‘func-
tional’’ or ‘‘non-ulcer’’ dyspepsia. [1,11–13] Recently some experts
have argued that GERD should be excluded from the etiologies of
dyspepsia and treated as a different entity, [2,14] but this is still in
dispute. [15,16]
There are several alternative strategies for initial management
of dyspepsia including empirical acid suppressive therapy, H. pylori
test and treat, and prompt endoscopy, [17,18] and several studies
have tried to find the best strategy. [11–13,18–20] It has been
suggested that the most cost-effective initial approach in primary
care, particularly in countries with low rates of H. pylori infection is
test and treat strategy. [17,21–23] However, it may delay early
diagnosis of malignant underlying disease beyond the point where
it is still curable and also might not be practical in countries with
very high rates of H. pylori infection, such as Iran. In addition,
endoscopy is an accurate but costly method of early diagnosis of
UGI malignancies, which are considered as the most important
causes of global cancer deaths. [24] It may be cost-effective to
stratify dyspeptic patients as high-risk and low-risk, and then
perform immediate endoscopy on the high-risk group while
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39173applying other alternatives for the low-risk group. Thus some
experts have recommended prompt endoscopy in newly diagnosed
dyspeptic patients having any alarm symptoms including uninten-
tional weight loss (.10% of body weight), dysphagia, GI bleeding,
persistent vomiting, abdominal palpable mass and anemia, as well
as in patients who are over age 50. [12,19,25–27] In contrast,
several studies have shown limited predictive value for either alarm
features or age to be able to differentiate low- and high-risk
dyspeptic patients for underlying malignancies. [28–33] Prompt
endoscopy in patients over 50 years regardless of alarm symptom
status has been shown to increase the proportion of curable cases
of UGI malignancies by as much as 30%, [34–36], but the cost-
effectiveness of initial endoscopy in this age group for improving
survival of cancer patients is uncertain. [36,37] Distinct UGI
malignancy incidence rates and various distributions of its
topographical types in different populations [7–10] as well as
differences in H. pylori infection rates [38,39] could partly explain
the variable results.
Gastric cancer, followed by esophageal cancer, is reported as
the most common cancer in Iranian men. As well, H. pylori
infection is highly prevalent (.80%) in the Iranian adult
population. [39–45] Although acid peptic disease is also still
common in Iran, [44,46] the major indication for UGI endoscopy
in Iran is ruling out upper GI malignancy as underlying cause. We
have conducted a relatively large-scale study to assess the role of
alarm symptoms and their diagnostic accuracy in predicting UGI
malignancy in patients with dyspepsia in a country with high
prevalence of H. pylori infection and upper GI malignancy.
Through developing a risk-prediction model, we also tried to find
a way to maximally use all information from age and alarm
symptoms, altogether, to find high-risk individuals for UGI
malignancy. To the best of our knowledge, no previous study
investigated alarm symptoms in Western Asia and Middle East
region.
Methods
Study population
All consecutive patients referred to Behrooz Clinic, a tertiary
referral gastroenterology clinic in Tehran, and diagnosed with
dyspepsia from 2002 to 2009 were invited to participate in this
study. Patients with UGI malignancy previously diagnosed
through other imaging tools, such as CT scan or barium swallow,
and patients who had already a diagnosis of UGI cancer or
undergone gastrectomy or esophagectomy (4 cases) were not
included in this study. All study participants signed a written
informed consent and Institutional Review Board of Digestive
Disease Research Institute of Tehran University of Medical
Sciences (TUMS) approved the study design and methods.
Exposure assessment
Demographic and anthropometric characteristics, history of any
alarm symptoms, family history of UGI malignancies in first
degree relatives, and also data on cigarette smoking status were
collected by interviewing the patients. Body mass (kg) and height
(cm) were measured; body mass index (BMI) was calculated and
categorized based on WHO recommendations. Pack-years (pys) of
cigarette smoking were calculated by multiplying duration of
smoking (in years) and daily use amount (in cigarettes per day
divided by 20). Accordingly, we categorized all patients into four
smoking groups: never smokers, ex-smokers (quit smoking more
than a year before interview), current light smokers (less than
20 pys) and current heavy smokers (20 pys or more). Rapid urease
test (RUT) was performed on all patients during endoscopy to
detect H. pylori infection. Alarm symptoms in this study were
unintentional weight loss ($10% of body weight in recent 6
months), dysphagia (perception of an impediment to the normal
passage of swallowed material), GI bleeding (any evidence of
hematemesis and/or melena), and persistent vomiting (at least 7 to
10 days of protracted vomiting). [47,48]
Outcome measurement
All patients underwent prompt endoscopy using Olympus
video-endoscopes (GIF type-160), while they were asked not to
use proton pump inhibitors (PPIs) or H2 blockers for at least 2
weeks prior to endoscopy to avoid their masking effect on visibility
of malignancy during endoscopy. [49] In case of any suspected
malignancy, multiple biopsy specimens were taken from the
suspected lesion and were sent to two separate pathology centers.
All cancer diagnoses were histologically confirmed. UGI malig-
nancy was defined as any histologically confirmed esophageal,
gastric or duodenal cancer detected during endoscopy.
Statistical Analysis
Using histology as the gold standard for diagnosis of UGI
malignancies, we calculated sensitivity, specificity, positive predic-
tive value (PPV), and negative predictive value (NPV). We also
calculated and present functions of sensitivity and specificity,
including positive diagnostic likelihood ratio (PDLR), negative
diagnostic likelihood ratio (NDLR), and diagnostic odds ratio
(OR), and their related 95% confidence intervals, as measures of
diagnostic accuracy for each individual alarm symptom. [50]
We estimated odds ratios (ORs) and 95% confidence intervals
for age, demographics, and each of alarm symptoms using
univariable and multivariable adjusted logistic regression models.
Adjusted model included age, gender, level of education, cigarette
smoking, history of weight loss, GI bleeding, persistent vomiting
and dysphagia. Based on regression model findings, we decided to
Figure 1. The risk scores and their corresponding risk probabilities derived from the suggested risk-prediction model.
doi:10.1371/journal.pone.0039173.g001
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four age categories: less than 36 years of age, between 36 and 49,
between 50 and 65 and finally 65 or older, as the patients in each
group were similar within the group and different from the other
groups in terms of OR.
We developed a risk-prediction model, through a backward
stepwise selection in a multivariable logistic regression analysis. We
used all variables that showed significant association with UGI
malignancy in univariable regression analysis, except for BMI and
H. pylori. BMI was not included because of its collinearity with
weight loss. H. pylori was not included because it was measured
during endoscopy (and not prior to that), so it was not helpful to
assess the need for endoscopy. We also included all possible two-
way interaction terms between four alarm symptoms in the initial
model. Subsequently, using an automated backward-stepwise
multivariable method, we removed the predictors with highest p
values on the basis of Wald test, so that achieving the final model
that only comprised by the predictors with a multivariable p value
of less than 0.05. Although forward selection gives a more
parsimonious model, backward selection is generally preferable if
stepwise selection is applied. [51] Since there were 46 missing
values in two variables; family history of UGI cancer (17 patients)
and level of education (29 patients) we performed the analyses on
2,801 remaining patients; 82 UGI malignancies. The complete case
analysis approach was applied, because of the small percentage of
missing values in only two variables that was considered to be
completely at random.
As the rule for prediction model, we used the linear predictor,
which is the sum of the products of regression coefficients with the
corresponding variable values from the final logistic model, and for
convenience added a constant value of 1.5 to ensure it was
positive; Risk Score=1.5+(Regression Coefficient6Variable Value)
The corresponding risk probability was calculated using the
equation; P=1/(1+e
2ß), where ß=Constant+(Regression Coefficient6
Variable Value); for example, probability (P) thresholds of 1%, 10%
and 25% correspond to risk score (RS) cutoff levels of 3.1, 5.5 and
6.6, respectively (Figure 1).
Three percent of all patients had UGI malignancies, hence we
chose thresholds of 1% and 10%, round numbers that were
approximately three times lower and higher than the overall
population average, to denote low- or high-risk, respectively.
Subsequently, we defined four risk groups for UGI malignancy:
low-risk group with a probability of less than 1%, intermediate-risk
group with a probability between 1% to 10%, high-risk group with
a probability of 10% to 25%, and excessive-risk group with a
probability of higher than 25%.
Once the variables to be included in the model were defined, we
examined the calibration of the model by performing Hosmer-
Lemeshow goodness-of-fit test. We also assessed the overall
performance of the model using Nagelkerke’s R
2-as a measure of
explained variation in log-likelihood scale, and Brier score (or
average prediction error). [52] Finally, the discrimination capa-
bility of the model was estimated using the area under the receiver
operating characteristic (ROC) curve or AUC and its 95% confidence
intervals. To further evaluating the discrimination ability of our
risk-prediction model, we compared it with two other models: 1)
age only; 2) age plus alarm symptoms; in terms of AUC (Figure 2).
We also plotted reclassification table and calculated net reclassi-
fication index (NRI) and integrated discrimination index (IDI),
investigating added discriminatory performance of our suggested
risk-prediction model compared to model 2. [53–58] In evaluating
model performance, over-fitting is a well-known statistical
phenomenon where a model will always perform better on the
data used to construct it than when predicting from independent
but similar data. While we had no data to externally validate our
model, we used repeated 10% cross-validation to guard against
over-fitting. [51,52] In this procedure the model was fitted to a
randomly selected 90% of the data then tested on the remaining
10%; the procedure then being repeated 10 times and the resulting
statistics averaged.
Figure 2. ROC curves based on three predictive model for upper GI malignancy in dyspeptic patients, including model1; only age
included, model2; age plus alarm symptoms, and model3; the risk-prediction model.
doi:10.1371/journal.pone.0039173.g002
Alarm Symptoms and Dyspepsia
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e39173All statistical analyses were conducted using STATA statistical
software, version 11 (STATA Corp, College Station, TX) and all
reported p-values are 2-sided.
Results
A total of 2,847 patients with dyspepsia who were referred to
Behrooz clinic, a tertiary GI clinic in Tehran, participated in this
study. Table 1 shows the demographic characteristics, as well as
habits and distribution of alarm symptoms in study participants.
The mean (6SD) age of the participants was 42.5 (615.0), and
approximately half (50.5%) were females. Of these, 1,131 patients
(39.7%) had at least one alarm symptom; the most common
reported alarm symptom was dysphagia (n=547; 19.2%).
UGI malignancies were histologically confirmed in 87 (3.1%)
cases. Compared to all patients with dyspepsia, patients with UGI
malignancies were significantly older (mean age of 58.0 years);
Table 1. Demographic characteristics, habits and distribution of alarm symptoms in all dyspeptic patients and who with upper GI
malignancy.
All patients with dyspepsia Dyspeptic patients with UGI malignancy P value*
Frequency
J percentage Frequency
J percentage
Age (6SD) 42.5615.0 58.0615.4 ,0.001
Gender
Female 1,439 50.5 34 39.1 0.030
Male 1,408 49.5 53 60.9
Education level
Less than high school 743 26.4 43 52.4 ,0.001
Higher education 2,075 73.6 27 47.6
Body Mass Index (kg/m
2)
Underweight (,18.5) 146 5.4 2 2.6 0.008
Normal (18.5–24.9) 1,310 48.5 52 67.5
Overweight (25–29.9) 965 35.7 19 24.7
Obese ($30) 282 10.4 4 5.2
History of weight loss
Negative 2,533 89.0 49 56.3 ,0.001
Positive 314 11.0 38 43.7
History of GI bleeding
Negative 2,435 85.5 66 75.9 0.009
Positive 412 14.5 21 24.1
History of persistent vomiting
Negative 2,525 88.7 63 72.4 ,0.001
Positive 322 11.3 24 27.6
History of dysphagia
Negative 2,300 80.8 61 70.1 0.010
Positive 547 19.2 26 29.9
Family history of upper GI cancer
Negative 2,583 91.3 74 85.1 0.037
Positive 247 8.7 13 14.9
Cigarette smoking
Never smoker 2,326 81.7 56 64.4 ,0.001
Ex-smoker 102 3.6 5 5.8
Current light smoker 328 11.5 13 14.9
Current heavy smoker 91 3.2 13 14.9
H. pylori test result
{
Negative 1,492 53.1 25 29.4 ,0.001
Positive 1,318 46.9 60 70.6
JSince we had some missing information in educational level, weigh, height, and H. pylori test results, the sum of frequencies in these variables is not equal to study
sample size.
{H. pylori infection was detected based on Rapid Urease Test (RUT), during endoscopy.
*P values are calculated using independent sample t-test for age and chi-square tests for other variables to compare the distribution of the variables between patients
with and without UGI malignancy.
doi:10.1371/journal.pone.0039173.t001
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high school diploma (52.4%); to have a family history of UGI
malignancies (14.9%); to have ever smoked cigarettes (35.6%); and
more likely to be positive for H. pylori (70.6%) (Table 1). Patients
reporting at least one of the alarm symptoms constituted 66.7% of
patients with UGI malignancies compared to 38.9% in patients
without cancer (p value,0.001).
Table 2 shows the endoscopic and histological findings in the
study participants. The most common endoscopic findings were
GERD (72.6%), followed by PUD (15.0%), and UGI malignancies
(3.1%). The Los Angeles (LA) classification was used for the
endoscopic diagnosis of GERD, which classifies it into 4
subgroups; A to D, according to number and length of observed
mucosal breaks and involvement of one or more mucosal folds.
[59] Of the 87 patients with cancer, 68 (78.2%) were diagnosed
with gastric cancer, 16 (18.4%) with esophageal cancer, and 3
(3.4%) with duodenal cancer. The majority of all malignancies
(54.0%) were well-differentiated. Esophageal cancers were located
more in the middle-third of the esophagus (68.7%) and were more
of squamous cell type (62.5%). The majority of gastric cancers
were adenocarcinomas (88.2%) and were located in the antrum
(35.3%). Of the 3 duodenal cancers, 2 (66.7%) were seen in D1.
(Table 2)
Table S1 shows diagnostic values for alarm symptoms for all
participants and by age category. The prevalence of UGI cancers
by age category, from youngest to oldest, was 0.71%, 1.89%,
3.65%, and 14.3%, respectively. Due to increasing prevalence of
cancer with age, PPV increased as a function of age. For example
PPV for dysphagia was nearly 16-fold higher in the oldest versus
the youngest group. Among alarm symptoms, weight loss was the
strongest predictor of UGI cancers.
We calculated diagnostic values for experiencing only one, two,
and more than two alarm symptoms, and at least one symptom,
compared to patients who had never experienced any alarm
symptoms, as reference group (Table S2). Positive predictive value
increased with increasing number of reported alarm symptoms
and older age, such that PPV increased from 0.70% in patients
younger than 35 years of age with only one alarm symptom to
58.3% in patients older than 65 years of age with more than two
alarm symptoms. Having at least one alarm symptom had the
highest sensitivity (66.7%) but the lowest specificity (61.1%).
We used multivariable adjusted logistic regression models to
study the independent diagnostic ORs for each alarm symptom
(Table 3). In these models, age showed very high ORs, in both
unadjusted and adjusted models, with OR (95%CI) of 22.8 (8.86–
58.5), for the oldest ($65 years old) compared to the youngest age
group; a near 2-fold increase in cancer odds was observed for each
10 years increase in age. Men did not have significantly higher
odds of UGI cancers than women. Heavy smokers were in a
significantly higher risk of developing UGI malignancies com-
pared to never-smokers (OR (95%CI): 5.07 (2.33–11.0)). Among
alarm symptoms, weight loss was the leading predictive factor for
UGI malignancy in adjusted models (OR (95%CI)=4.89 (2.91–
8.23)), while persistent vomiting with OR (95%CI) of 2.26 (1.27–
4.03) was the second most important alarm symptom. Patients
with UGI cancer were approximately twice as likely to have
positive RUT results compared to patients without malignancy,
mainly due to the association between H. pylori and gastric cancer
(OR (95%CI)=3.05 (1.65–5.64)).
As fully explained in the methods part, we developed a risk-
prediction model to predict UGI malignancies in dyspeptic
patients (Table 4). Figure 1 shows the risk score (RS) thresholds
and their corresponding risk probabilities, as described in the
methods section; low-risk group with a RS,3.1; intermediate-risk
group with a 3.1#RS,5.5; high-risk group with a 5.5#RS,6.5;
and excessive-risk group with a RS of $6.6. To provide some
examples, a 35-year-old never-smoker who did not have any of the
alarm symptoms had a risk score of 1.5 and was categorized as
Table 2. Endoscopic and histologic findings in study
population.
Frequency Percent
GE Reflux Disease (GERD)
No GERD 781 27.4
GERD-A 1,555 54.6
GERD-B 443 15.6
GERD-C 64 2.3
GERD-D 4 0.1
Peptic Ulcer Disease (PUD)
No PUD 2,420 85.0
Duodenal ulcer 393 13.8
Gastric ulcer 27 0.9
Synchronous ulcer 7 0.3
Upper GI Malignancy
No malignancy 2,760 96.9
Esophageal 16 0.6
Gastric 68 2.4
Duodenal 3 0.1
Cancer Grade
Esophageal Well-diff 12 75.0
Intermediate-diff 4 25.0
Poor-diff 0 0.0
Gastric Well-diff 35 51.5
Intermediate-diff 27 39.7
Poor-diff 6 8.8
Duodenal Well-diff 0 0.0
Intermediate-diff 3 100
Poor-diff 0 0.0
Cancer Morphology
Esophageal SCC 10 62.5
Adenocarcinoma 6 37.5
Gastric Adenocarcinoma 60 88.2
MALT 8 11.8
Duodenal Adenocarcinoma 3 100
Cancer Topography
Esophageal Upper third 2 12.5
Middle third 11 68.7
Lower third 3 18.8
Gastric GE junction 4 5.9
Cardia 14 20.6
Corpus 22 32.3
Antrum 24 35.3
Diffuse 4 5.9
Duodenal D1 2 66.7
D2 1 33.3
doi:10.1371/journal.pone.0039173.t002
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current heavy smoker with weight loss but no other alarm
symptoms had a score of 7.9 (=1.5+3.3+1.3+1.8) and was
therefore categorized as excessive-risk (.25% chance of cancer).
Using RS=2.2(or 5.5, or 6.6) as the cutoff levels, the estimated
sensitivity and specificity was equal to 100% (or 42.0%, or 29.6%)
and 24.5% (or 95.0%, or 98.9%), respectively (Table 5).
The suggested risk-prediction model, including 8 predictors,
had the number of events per variable (EPV) of about 10, which
indicates an acceptable sample size to provide an adequate risk-
prediction model. [52] As shown in Table 6, a nonsignificant
Table 3. Estimated odds ratios of demographic characteristics and alarm symptoms for upper GI malignancies, based on
unadjusted and multivariable adjusted regression models.
OR for Upper GI Cancers
Unadjusted model Multivariable adjusted model
J
Age categories
#35 years old ref ref
36–49 years old 2.83 (1.19–6.77) 4.13 (1.60–10.6)
50–64 years old 5.51 (2.36–12.9) 6.83 (2.68–17.4)
$65 years old 23.4 (10.3–53.2) 22.8 (8.86–58.5)
Gender
Female ref ref
Male 1.62 (1.04–2.50) 1.39 (0.82–2.38)
Education level
Higher education ref ref
Less than high school 3.21 (2.06–4.99) 1.51 (0.89–2.57)
History of weight loss
Negative ref ref
Positive 6.98 (4.49–10.8) 4.89 (2.91–8.23)
History of GI bleeding
Negative ref ref
Positive 1.93 (1.17–3.19) 1.77 (1.01–3.10)
History of persistent vomiting
Negative ref ref
Positive 3.15 (1.94–5.11) 2.26 (1.27–4.03)
History of dysphagia
Negative ref ref
Positive 1.83 (1.15–2.93) 1.16 (0.66–2.05)
Family history of upper GI cancer
Negative ref ref
Positive 1.88 (1.03–3.45) 2.00 (1.01–3.95)
Cigarette smoking
Never smoker ref ref
Ex-smoker 2.09 (0.82–5.33) 0.88 (0.25–3.08)
Current light smoker 1.67 (0.90–3.09) 2.03 (1.02–4.04)
Current heavy smoker 6.75 (3.55–12.9) 5.07 (2.33–11.0)
Body mass index (Kg/m
2)
Under weight (,18.5) 0.34 (0.08–1.39) 0.48 (0.10–2.17)
Normal weight (18.5–24.9) ref ref
Over weight (25–29.9) 0.48 (0.28–0.83) 0.65 (0.36–1.18)
Obese ($30) 0.35 (0.12–0.97) 0.59 (0.20–1.71)
H. Pylori test result
{
Negative ref ref
Positive 2.80 (1.74–4.49) 2.08 (1.24–3.47)
JMultivariable model is adjusted for age, gender, educational level, cigarette smoking and history of weight loss, GI bleeding, persistent vomiting and dysphagia.
{H. pylori infection is detected based on Rapid Urease Test (RUT), during endoscopy.
doi:10.1371/journal.pone.0039173.t003
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quately predicts, for each level of risk, the percentage of patients
with the outcome (good calibration). The comparison of Brier
score and Nagelkerke’s R
2 measures in three models, suggested
slightly better overall performance for the risk-prediction model.
The Akaike information criterion (AIC) was in favor of the
proposed risk-prediction model (model3); however, the Bayesian
information criterion (BIC) didn’t show any superiority for model3
versus model2. The net reclassification index (NRI) of 23%
compared to model2, again advocated for the third model;
however, the integrated discrimination index (IDI), which was
calculated by subtracting discrimination slopes of compared
models, indicated a minor improvement in discrimination ability
of model3 versus model2; 4.3% (Table 6). The estimated AUC
comparison showed a statistically significant higher discriminatory
capacity of model3, though not substantially; the AUC (95% CI) of
0.852 (0.812–0.893) for risk-prediction model was significantly
higher than both model2 (p=0.022) with AUC (95% CI) of 0.822
(0.774–0.870) and model1 (p,0.001) with AUC (95% CI) of 0.760
(0.709–0.812) (Figure 2).
Using the marginal numbers of a reclassification table (Table 7),
we evaluated the calibration of the risk-prediction model
compared to model2, which demonstrated comparable predicted
probabilities with observed proportions, except in the third group,
with risk probabilities between 10% and 25%.
The results of repeated 10% cross-validation indicated that the
estimated average of AUC from risk-prediction model (0.820;
95%CI: 0.764–0.876) was not largely different from the average
AUC in validation set (0.796; 95%CI: 0.744–0.848); 0.024.
Discussion
We studied age and several alarm symptoms to learn whether
they can provide useful diagnostic information to classify dyspeptic
patients, referred to a tertiary GI clinic, as high-risk and low-risk
for UGI cancers.
In the adjusted models, older age, history of weight loss, history
of GI bleeding, persistent vomiting, being current cigarette
smoker, family history of UGI cancer, and H. pylori positivity
were all positively associated with risk of UGI cancers. Of these,
age and weight loss were the most important predictors. Other
predictors, such as male sex, lower education, and history of
dysphagia were also associated with higher risk in unadjusted
models, but lost statistical significance in the adjusted models.
Since we measured H. pylori infection by rapid-urease-test (RUT)
during endoscopy, this variable wasn’t included in risk-prediction
model. Moreover, the majority of H. Pylori infected gastric cancer
patients develop severe gastric atrophy before gastric cancer,
making stomach environment unfavorable for H. pylori survival,
and thus would become H. pylori negative by RUT.
Some previous studies have also assessed the value of age and
alarm symptoms in predicting risk of cancer in dyspeptic patients.
[28,60,61] Bai and colleagues studied the predictive value of alarm
symptoms and age for UGI malignancy in China and found
limited value for either age or any alarm symptoms. [61] In their
study, alarm symptoms were highly specific but had low sensitivity.
However, they based most of their discussion on PDLR of each
symptom and did not build models using all predictor variables to
predict risk of UGI malignancies. Performing a meta-analysis,
Fransen and colleagues found limited diagnostic values including
sensitivity, specificity and predictive values, for each individual
alarm symptom, i.e., dysphagia, weight loss, bleeding, and
vomiting. [33] They suggested using alarm symptoms in combi-
nation with other factors – such as age, gender, or smoking –
might be a better tool for selection of high-risk patients; however
they were unable to test their hypothesis. Kapoor et al., [28] built a
model using a number of alarm symptoms and age, and validated
their model in another group of patients. Using a combination of
symptoms, they were able to generate a model with high sensitivity
and high NPV, but low specificity and low PPV, to predict risk of
UGI malignancies. However, they did not use the weight of the
Table 4. Risk-prediction model for predicting risk of upper GI
malignancy in dyspeptic patients.
Regression Coefficient
(95%CI) P value
Age categories
36–49 yrs old 1.3 (0.4 to 2.3) 0.006
50–64 yrs old 1.9 (1.0 to 2.9) ,0.001
$65 yrs old 3.3 (2.4 to 4.2) ,0.001
Weight loss 1.3 (0.6 to 1.9) ,0.001
Persistent vomiting 0.9 (0.3 to 1.5) 0.003
GI bleeding 1.0 (0.4 to 1.6) 0.002
Weight loss6Dysphagia 1.1 (0.3 to 2.0) 0.012
GI bleeding6Dysphagia 21.5 (22.8 to 20.1) 0.037
Family history of upper GI cancer 0.7 (0.0 to 1.4) 0.048
Cigarette smoking
Current light smokers 0.8 (0.1 to 1.5) 0.017
Current heavy smokers 1.8 (1.0 to 2.5) ,0.001
Constant 26.2 (27.1 to 25.3) ,0.001
doi:10.1371/journal.pone.0039173.t004
Table 5. The diagnostic characteristics of choosing different risk score cut-off levels, derived from the risk-prediction model.
Thresholds for risk score Sensitivity% Specificity% Correctly classified% No. patients
£ No. missing cancers
J Probability%
¥
RS$2.2 100 24.5 26.7 749 0 0.4
RS$3.1 93.8 51.6 52.8 1,408 5 1
RS$4.2 76.5 78.9 78.9 2,211 20 3
RS$5.5 42.0 95.0 93.5 2,634 47 10
RS$6.6 29.6 98.9 96.9 2,749 57 25
£The number of patients that have a RS of less than the chosen threshold.
JThe number of cancer patients that have a RS of less than the chosen threshold and consequently are missed, due to not being selected for prompt endoscopy.
¥The probability of having cancer when the RS is exactly equal to the threshold, according to mentioned formulae in the method section.
doi:10.1371/journal.pone.0039173.t005
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of the full extent of information in their dataset. Finally, Numans
and colleagues [60] developed a risk-prediction model using
calculated total scores and showed that classical alarm symptoms,
via a risk-prediction model, are useful predictors of UGI
malignancy. However, their model is somewhat complex and,
with inclusion of several variables, somewhat unstable. Like the
results of our study, nearly all of these studies showed relatively low
value for each alarm symptom, but perhaps a number of
unnecessary endoscopies could be avoided using a combination
of symptoms.
Although we found several variables that were each associated
with higher risk of having cancer, our results showed that no single
predictor could perfectly differentiate between high- and low-risk
groups; sensitivities and specificities for each of the predictors were
far from one. In principle, simply adding the number of risk factors
is not the most efficient use of data, as different risk factors
predicted cancer with substantially different odds ratios. There-
fore, the most appropriate way of predicting risk would be using
the risk-prediction model. However, our results show that the
proposed risk-prediction model was unable to provide any
important improvement in prediction compare to a model based
on including only age and the generally accepted alarm symptoms.
Our proposed risk-prediction model was not perfect, despite
acceptable overall model fit and calibration. However, such model
could somewhat adequately discriminate patients in our setting
into a wide range, with risks less than 1% to risks over 25%, with
acceptable calibration. Given that all of the predictors used in this
risk-prediction model could easily be obtained from a simple
questionnaire, this might provide useful information for the
physician in deciding whether to perform immediate endoscopy
or to first try empiric forms of treatment.
Some predictors of cancer, such as dysphagia, were not
statistically significantly associated with odds of cancer and were
excluded from our model. Recent studies showed that dysphagia
could be, more often, considered as a GERD symptom, rather
than esophageal cancer. [62] Owing the fact that the majority
(72.6%) of study participants were GERD patients, finding no
significant associations shouldn’t be surprising. Furthermore, most
esophageal cancer patients with dyspepsia are relatively elderly
patients and dysphagia indicate that the cancer is beyond the point
of curability, [63] therefore, use of this risk-prediction model
would perhaps not be a significant risk to them.
Making a decision as to perform endoscopy versus provide other
treatments first requires a careful cost-benefit analysis. Such
analysis depends partly on the risk-prediction model but it needs to
take into consideration other factors such as probability of missing
a potentially curable cancer if the treatment is delayed by a few
weeks; additional benefits of endoscopy such as diagnosis of
conditions other than cancer, as well as its harms and cost;
prevalence of cancer and other underlying diseases causing
dyspepsia; availability of endoscopic facilities; and its cost in any
specific health setting.
Table 6. Performance of three different models for predicting UGI malignancy in dyspeptic patients.
Performance measure Prediction Models*
Model1 Model2 Model3
Overall
Brier 0.027 0.025 0.024
Brierscaled ** 4.2% 12.0% 16.5%
R
2 (Nagelkerke) 12.9% 22.3% 26.9%
Discrimination
Area under ROC 0.760 (0.709 to 0.812) 0.822 (0.774 to 0.870) 0.852(0.812 to 0.893)
Discrimination slope 0.043 0.115 0.158
Calibration
Hosmer-Lemeshow test X
2 (df:2)=0.30 X
2 (df:6)=2.90 X
2 (df:8)=5.45
P=0.86 P=0.82 P=0.71
Global model fit
Akaike information criterion (AIC) 663.5 607.4 583.9
Bayesian information criterion (BIC) 687.2 655.0 655.2
Reclassification
Net improvement index (NRI)
Model2 vs. Model1 22.3%
Model3 vs. Model1 42.2%
Model3 vs. Model2 23.3%
Integrated discrimination index (IDI)
Model2 vs. Model1 7.2%
Model3 vs. Model1 11.5%
Model3 vs. Model2 4.3%
*Model1: age only; Model2: age plus four alarm symptoms (weigh loss, persistent vomiting, GI bleeding, dysphagia); Model3: risk-prediction model.
**Brierscaled=12Brier/Briermax, where Briermax=mean(p)6(12mean(p)); and mean(p) is mean probability of outcome prediction based on model.
doi:10.1371/journal.pone.0039173.t006
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pylori and UGI malignancy prevalence is low, while the cost of
upper GI endoscopy is very high, cost-effectiveness analysis usually
reveal that initial endoscopy is not beneficial and a test and treat
approach is the most cost-efficient strategy. [64] However,
applying a validated risk-prediction model to find high-risk
patients for UGI malignancies and targeting them for performing
endoscopy might be an alternative strategy to better compare the
cost-benefit of two approaches. Furthermore, for Asian countries
such as China and Iran, this recommendation, probably would not
be applicable. [61] Unless, non-invasive and cheaper tests become
available in countries like Iran, where endoscopy is widely
available with a relatively low cost, prompt endoscopy may be
recommended in all dyspeptic patients older than 50, with weight
loss, or with any additional alarm symptoms.
The strengths of our study are relatively large sample size,
availability of data on at least 10 predictors, and constructing risk-
prediction model. A limitation of the study is that the risk-
prediction model was based on a development (training) set and
there was no external validation set.
In summary, none of the predictors that we studied demon-
strated high diagnostic accuracy. Using age, alarm symptoms,
family history of UGI cancer and smoking, we were able to
construct a useful risk-prediction model that distinguished between
high-risk and low-risk individuals with a ROC curve AUC of 0.85
and adequate overall calibration and model fit measures.
However, the decision on how to use this model will depend on
cost-benefit analytic models that depend on several other factors.
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